What is RGC's current stock price?

RGC (Regencell Bioscience Holdings Limited) is currently trading at $25.80 with a market cap of $12.76B.

What sector is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited (RGC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

InvestLog

RGC Regencell Bioscience Holdings Limited

Healthcare

$25.80-4.44%ClosedMarket Cap: $12.76B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

10462.52

P/S

0.00

EV/EBITDA

-1814.43

DCF Value

$0.00

FCF Yield

0.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-231.9%

ROA

-233.9%

ROIC

-444.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q2 null	$0.00	$-5.3M	$—
Q4 null	$0.00	$-1.7M	$—
FY null	$0.00	$-3.6M	$—
Q2 null	$0.00	$-1.9M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

2 Strong Buy7 Buy5 Hold1 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

LO WILLIAM WING YAN DRdirector

SellWed Mar 18

LO MARGARET HOOR HANdirector

SellWed Mar 18

LO MARGARET HOOR HANdirector

SellWed Mar 18

HUI EVANA YEE WAHdirector

SellWed Mar 18

CHUNG JAMES WAI HONGdirector, officer: COO and Chief Strategy Officer

SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

1.85

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Peers

ATR